tipifarnib has been researched along with lenvatinib in 2 studies
Studies (tipifarnib) | Trials (tipifarnib) | Recent Studies (post-2010) (tipifarnib) | Studies (lenvatinib) | Trials (lenvatinib) | Recent Studies (post-2010) (lenvatinib) |
---|---|---|---|---|---|
309 | 92 | 94 | 975 | 112 | 946 |
Protein | Taxonomy | tipifarnib (IC50) | lenvatinib (IC50) |
---|---|---|---|
Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | 0.0162 | |
Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.039 | |
Platelet-derived growth factor receptor alpha | Homo sapiens (human) | 0.051 | |
Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.022 | |
Kinesin-1 heavy chain | Homo sapiens (human) | 0.01 | |
Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.0052 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.0035 | |
Nuclear receptor coactivator 4 | Homo sapiens (human) | 0.01 | |
Coiled-coil domain-containing protein 6 | Homo sapiens (human) | 0.01 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Atkins, J; Busaidy, N; Fu, S; Hong, D; Kurzrock, R; Naing, A; Sherman, S; Wheler, J | 1 |
1 trial(s) available for tipifarnib and lenvatinib
Article | Year |
---|---|
Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy.
Topics: Adult; Aged; Aged, 80 and over; Anilides; Antineoplastic Agents; Biomarkers, Tumor; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Disease Progression; Female; Humans; Indoles; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-ret; Pyridines; Pyrroles; Quinolines; Quinolones; Retrospective Studies; Sorafenib; Sunitinib; Thyroid Neoplasms; Treatment Outcome; Valproic Acid | 2013 |
1 other study(ies) available for tipifarnib and lenvatinib
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |